Menu
GWAS Study

Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.

Lesseur C, Diergaarde B, Olshan AF et al.

27749845 PubMed ID
GWAS Study Type
12619 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LC
Lesseur C
DB
Diergaarde B
OA
Olshan AF
WV
Wünsch-Filho V
NA
Ness AR
LG
Liu G
LM
Lacko M
EJ
Eluf-Neto J
FS
Franceschi S
LP
Lagiou P
MG
Macfarlane GJ
RL
Richiardi L
BS
Boccia S
PJ
Polesel J
KK
Kjaerheim K
ZD
Zaridze D
JM
Johansson M
MA
Menezes AM
CM
Curado MP
RM
Robinson M
AW
Ahrens W
CC
Canova C
ZA
Znaor A
CX
Castellsagué X
CD
Conway DI
HI
Holcátová I
MD
Mates D
VM
Vilensky M
HC
Healy CM
SN
Szeszenia-Dąbrowska N
FE
Fabiánová E
LJ
Lissowska J
GJ
Grandis JR
WM
Weissler MC
TE
Tajara EH
NF
Nunes FD
DC
de Carvalho MB
TS
Thomas S
HR
Hung RJ
PW
Peters WH
HR
Herrero R
CG
Cadoni G
BH
Bueno-de-Mesquita HB
SA
Steffen A
AA
Agudo A
SO
Shangina O
XX
Xiao X
GV
Gaborieau V
CA
Chabrier A
AD
Anantharaman D
BP
Boffetta P
AC
Amos CI
MJ
McKay JD
BP
Brennan P
Chapter II

Abstract

Summary of the research findings

We conducted a genome-wide association study of oral cavity and pharyngeal cancer in 6,034 cases and 6,585 controls from Europe, North America and South America. We detected eight significantly associated loci (P < 5 × 10-8), seven of which are new for these cancer sites. Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5). Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-HLA-DQB1*0603 (odds ratio (OR) = 0.59, P = 2.7 × 10-9). Stratified analyses on a subgroup of oropharyngeal cases with information available on human papillomavirus (HPV) status indicated that this association was considerably stronger in HPV-positive (OR = 0.23, P = 1.6 × 10-6) than in HPV-negative (OR = 0.75, P = 0.16) cancers.

2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls

Chapter III

Study Statistics

Key metrics and study information

12619
Total Participants
GWAS
Study Type
No
Replicated
NR, European, Hispanic or Latin American
Ancestry
Argentina, Sweden, U.S., Poland, Cuba, Czech Republic, Brazil, Italy, Russian Federation, Netherlands, Romania, Greece, Canada, Germany, U.K., Croatia, Spain, Slovakia, France, Republic of Ireland, Norway
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.